Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 17 studies | 28% ± 9% | |
ciliated cell | 10 studies | 29% ± 12% | |
connective tissue cell | 9 studies | 27% ± 9% | |
epithelial cell | 9 studies | 35% ± 20% | |
basal cell | 6 studies | 22% ± 11% | |
oligodendrocyte precursor cell | 6 studies | 31% ± 10% | |
pericyte | 5 studies | 19% ± 4% | |
smooth muscle cell | 5 studies | 20% ± 4% | |
goblet cell | 5 studies | 22% ± 6% | |
progenitor cell | 4 studies | 18% ± 3% | |
adventitial cell | 4 studies | 27% ± 6% | |
acinar cell | 4 studies | 49% ± 30% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 45% ± 5% | |
hepatocyte | 4 studies | 50% ± 26% | |
pancreatic A cell | 3 studies | 36% ± 9% | |
endothelial cell | 3 studies | 25% ± 5% | |
luminal cell of prostate epithelium | 3 studies | 26% ± 1% | |
glutamatergic neuron | 3 studies | 28% ± 7% | |
neuron | 3 studies | 33% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 7350.08 | 226 / 226 | 99% | 114.94 | 401 / 406 |
prostate | 100% | 2384.25 | 244 / 245 | 99% | 133.92 | 496 / 502 |
esophagus | 100% | 2593.51 | 1444 / 1445 | 98% | 66.87 | 180 / 183 |
lung | 99% | 2392.47 | 575 / 578 | 99% | 122.56 | 1139 / 1155 |
breast | 100% | 2628.70 | 459 / 459 | 98% | 136.00 | 1094 / 1118 |
stomach | 100% | 3135.48 | 359 / 359 | 98% | 49.14 | 279 / 286 |
pancreas | 99% | 2936.92 | 325 / 328 | 98% | 51.28 | 174 / 178 |
intestine | 100% | 4649.28 | 966 / 966 | 96% | 57.25 | 507 / 527 |
bladder | 100% | 2987.29 | 21 / 21 | 94% | 56.16 | 476 / 504 |
ovary | 100% | 2453.47 | 180 / 180 | 90% | 31.33 | 389 / 430 |
skin | 99% | 3003.24 | 1796 / 1809 | 87% | 44.53 | 412 / 472 |
uterus | 100% | 1945.02 | 170 / 170 | 85% | 49.49 | 389 / 459 |
thymus | 100% | 2231.25 | 652 / 653 | 84% | 30.00 | 507 / 605 |
kidney | 100% | 2346.55 | 89 / 89 | 81% | 38.03 | 729 / 901 |
brain | 70% | 503.47 | 1851 / 2642 | 72% | 21.67 | 510 / 705 |
adrenal gland | 100% | 2637.48 | 258 / 258 | 34% | 9.71 | 78 / 230 |
adipose | 100% | 3697.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 55.56 | 1 / 1 |
blood vessel | 100% | 3025.36 | 1334 / 1335 | 0% | 0 | 0 / 0 |
spleen | 95% | 808.68 | 229 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 46.03 | 38 / 45 |
heart | 79% | 1132.60 | 680 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 38% | 8.53 | 11 / 29 |
eye | 0% | 0 | 0 / 0 | 30% | 8.00 | 24 / 80 |
peripheral blood | 22% | 657.22 | 205 / 929 | 0% | 0 | 0 / 0 |
muscle | 12% | 85.26 | 97 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015012 | Biological process | heparan sulfate proteoglycan biosynthetic process |
GO_0006065 | Biological process | UDP-glucuronate biosynthetic process |
GO_0030206 | Biological process | chondroitin sulfate biosynthetic process |
GO_0048666 | Biological process | neuron development |
GO_0034214 | Biological process | protein hexamerization |
GO_0006024 | Biological process | glycosaminoglycan biosynthetic process |
GO_0001702 | Biological process | gastrulation with mouth forming second |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0051287 | Molecular function | NAD binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003979 | Molecular function | UDP-glucose 6-dehydrogenase activity |
Gene name | UGDH |
Protein name | UDP-glucose 6-dehydrogenase Alternative protein UGDH UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22) |
Synonyms | |
Description | FUNCTION: Catalyzes the formation of UDP-alpha-D-glucuronate, a constituent of complex glycosaminoglycans . Required for the biosynthesis of chondroitin sulfate and heparan sulfate. Required for embryonic development via its role in the biosynthesis of glycosaminoglycans (By similarity). Required for proper brain and neuronal development . . |
Accessions | ENST00000510490.1 D6RHF4 E7ER95 E7EV97 O60701 ENST00000506179.5 [O60701-1] ENST00000515021.5 ENST00000514106.5 ENST00000501493.6 [O60701-2] E9PBD2 ENST00000507089.5 [O60701-3] ENST00000505698.1 E7ER83 L8E902 ENST00000503779.5 ENST00000509391.1 E7ETF4 ENST00000316423.11 [O60701-1] ENST00000510881.5 |